Page 146 - Journal of Special Operations Medicine - Spring 2015
P. 146

CoTCCC Meeting

                                             3–4 February 2015
                                               Atlanta, Georgia

                                         Selected Meeting Highlights



                                        Dr Frank Butler; COL Lance Cordoni








          3 February 2015                                         to Combat Gauze. They have not been tested in
                                                                  the US Army Institute of Surgical Research safety
          1.  Combat Medic Presentation: SFC Matthew Hoard, a     model, but both are chitosan­based products in a
             Special Forces medic, discussed a case in Afghanistan   gauze format (similar to the previously used Hem­
             in 2013 where an RPG­7 round impacted an RG­33       Con  dressings) and no adverse events were noted
                                                                      ®
             armored vehicle and resulted in bilateral lower ex­  as a result of HemCon use during the 4 years that
             tremity injuries to a team member. The Junctional    it was fielded as the US Army and USSOCOM he­
             Emergency Treatment Tool (JETT ) was applied         mostatic dressing of choice.
                                            ™
             and was effective at halting the junctional bleeding;   b. The recent change in fluid resuscitation from hem­
             however, two issues arose. First, the JETT became    orrhagic  shock  in TCCC  recommended  the fol­
             dislodged during patient transfer; second, the receiv­  lowing order of precedence:
             ing FST was unfamiliar with the JETT device and cut   1. Whole blood
             it off upon patient arrival. The Soldier later died of   2. 1:1:1 RBCs:thawed fresh frozen plasma (FFP):
             wounds.                                                 platelets
                The Abdominal Aortic and Junctional Tourni­       3. 1:1 RBCs:FFP
             quet (AAJT) was also discussed and it was noted      4. Four­way tie: Liquid (never frozen) plasma,
                ™
             that the AAJT is now approved for a 4­hour applica­     thawed FFP, reconstituted dried plasma, RBCs
             tion, but in testing at the US Army Institute of Sur­   only
             gical Research (USAISR), a Combat Ready Clamp        8. Hextend
             (CRoC ) applied at the umbilicus in order to occlude   9. Lactated Ringer’s or Plasma­Lyte  A
                                                                                                 ®
                   ™
             flow in the distal abdominal aorta (analogous to the   c.  Damage Control Resuscitation, as developed
             AAJT) for 2 hours resulted in muscle necrosis and    by  the  US  Army  Institute  of  Surgical  Research
             bowel ischemia. Application of the AAJT also results   (USAISR) and implemented by the DoD’s Joint
             in significant pain (as do extremity tourniquets) and   Trauma System (JTS), has been definitively proven
             is difficult for a casualty to tolerate.             to save lives. Efforts to expand prehospital blood
                                                                  product use should be continued and expanded.
          2.  TCCC Update: CAPT (Ret) Frank Butler, Chairman    d. Normal saline (NS) is NOT recommended due to
             of the CoTCCC, provided a review of recent changes   studies showing that NS is associated with hyper­
             to the TCCC Guidelines and other current TCCC        chloremic metabolic acidosis.
             issues.                                            e.  Tourniquets: A 2­hour re­check of tourniquets
             a. Combat  Gauze  remains the first choice for a     applied during Care Under Fire or Tactical Field
                             ™
               hemostatic dressing in TCCC. ChitoGauze  and       Care to determine if tourniquet removal is feasible
                                                     ®
               Celox Gauze are acceptable alternatives if Com­    and hemorrhage control can be maintained with
               bat Gauze is not available. These two hemostatic   Combat Gauze or other means is now manda­
               dressings have been shown to be equal in efficacy   tory. This does not replace the frequent re­checks



                                                          136
   141   142   143   144   145   146   147   148   149   150   151